About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Epha2Gt(KST085)Byg
gene trap KST085, BayGenomics
MGI:3688255
Summary 2 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Epha2Gt(KST085)Byg/Epha2Gt(KST085)Byg involves: 129P2/OlaHsd * C57BL/6 * FVB/N MGI:3689377
ht2
Epha2Gt(KST085)Byg/Epha2+ involves: 129P2/OlaHsd * C57BL/6 * FVB/N MGI:3689382


Genotype
MGI:3689377
hm1
Allelic
Composition
Epha2Gt(KST085)Byg/Epha2Gt(KST085)Byg
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6 * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Epha2Gt(KST085)Byg mutation (1 available); any Epha2 mutation (96 available)
phenotype observed in females
phenotype observed in males
N normal phenotype

Development of progressive cataract in Epha2Gt(KST085)Byg/Epha2Gt(KST085)Byg mice

neoplasm
• following skin tumor initiation and promotion by DMBA and TPA tumor latency is decreased by 2 - 3 weeks, tumor incidence is increased 7 fold at 10 weeks after onset of treatment, and tumor growth is increased
• proliferation of skin tumor cells is increased
• following a skin tumor initiation and promotion protocol using DMBA and TPA for 16 weeks the rate of malignant conversion of tumors is about twice that of wild-type mice

vision/eye
• mice develop progressive cortical cataracts
• onset of lens opacity occurs as early as 1 month of age
• bilateral lens opacity is observed at 5 months unlike in wild-type mice
• mature cataracts with lens rupture occurs between 6 and 8 months
• by 12 months, over 80% of mice exhibit cataracts

homeostasis/metabolism
• following skin tumor initiation and promotion by DMBA and TPA tumor latency is decreased by 2 - 3 weeks, tumor incidence is increased 7 fold at 10 weeks after onset of treatment, and tumor growth is increased
• proliferation of skin tumor cells is increased

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
cataract 6 multiple types DOID:0110229 OMIM:116600
J:151310




Genotype
MGI:3689382
ht2
Allelic
Composition
Epha2Gt(KST085)Byg/Epha2+
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6 * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Epha2Gt(KST085)Byg mutation (1 available); any Epha2 mutation (96 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
• following tumor initiation and promotion by DMBA and TPA increase in tumor incidence and growth, and decrease in tumor latency is intermediate between wild-type and homozygous mice
• proliferation of skin tumor cells is increased similar to increase in homozygous mice
• however, the rate of malignant conversion of tumors is similar to wild-type

homeostasis/metabolism
• following tumor initiation and promotion by DMBA and TPA increase in tumor incidence and growth, and decrease in tumor latency is intermediate between wild-type and homozygous mice
• proliferation of skin tumor cells is increased similar to increase in homozygous mice
• however, the rate of malignant conversion of tumors is similar to wild-type





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
07/02/2024
MGI 6.13
The Jackson Laboratory